Secreted bioactive factors fromBifidobacterium infantisenhance epithelial cell barrier function

Julia B. Ewaschuk1, Hugo Díaz, Liisa Meddings, Brendan Diederichs, Andrea L. Dmytrash, Jody Backer, Mirjam Looijer-van Langen, Karen Madsen2
1University of Alberta, Edmonton, Alberta, Canada T6G 2N8.
2University of Alberta

Tóm tắt

Live probiotic bacteria are effective in reducing gut permeability and inflammation. We have previously shown that probiotics release peptide bioactive factors that modulate epithelial resistance in vitro. The objectives of this study were to determine the impact of factors released from Bifidobacteria infantis on intestinal epithelial cell permeability and tight junction proteins and to assess whether these factors retain their bioactivity when administered to IL-10-deficient mice. B. infantis conditioned medium (BiCM) was applied to T84 human epithelial cells in the presence and absence of TNF-α and IFN-γ. Transepithelial resistance (TER), tight junction proteins [claudins 1, 2, 3, and 4, zonula occludens (ZO)-1, and occludin] and MAP kinase activity (p38 and ERK) were examined. Acute effects of BiCM on intestinal permeability were assessed in colons from IL-10-deficient mice in Ussing chambers. A separate group of IL-1-deficient mice was treated with BiCM for 4 wk and then assessed for intestinal histological injury, cytokine levels, epithelial permeability, and immune response to bacterial antigens. In T84 cells, BiCM increased TER, decreased claudin-2, and increased ZO-1 and occludin expression. This was associated with enhanced levels of phospho-ERK and decreased levels of phospho-p38. BiCM prevented TNF-α- and IFN-γ-induced drops in TER and rearrangement of tight junction proteins. Inhibition of ERK prevented the BiCM-induced increase in TER and attenuated the protection from TNF-α and IFN-γ. Oral BiCM administration acutely reduced colonic permeability in mice whereas long-term BiCM treatment in IL-10-deficient mice attenuated inflammation, normalized colonic permeability, and decreased colonic and splenic IFN-γ secretion. In conclusion, peptide bioactive factors from B. infantis retain their biological activity in vivo and are effective in normalizing gut permeability and improving disease in an animal model of colitis. The effects of BiCM are mediated in part by changes in MAP kinases and tight junction proteins.

Từ khóa


Tài liệu tham khảo

10.1080/003655200750056637

10.1074/jbc.M703576200

10.1016/S0140-6736(08)60207-X

10.4049/jimmunol.171.11.6164

10.1196/annals.1326.017

Clarkson T.Measurement of short-circuit current and ion transport across the ileum.Am J Physiol206: 658–668, 1964.

10.1097/01.inf.0000154588.79356.e6

10.1126/science.1110591

10.1097/00075198-200304000-00011

10.1073/pnas.0706625104

10.1017/S0029665107005563

10.1016/S0002-9440(10)61243-6

10.1093/ajcn/73.2.465s

10.1152/ajpcell.00113.2001

10.1046/j.1365-2168.2000.01615.x

10.1016/S0074-7742(04)59008-6

10.1542/peds.2004-2137

10.1159/000097449

10.1016/j.clim.2007.08.017

10.1172/JCI113938

10.1053/gast.2001.27224

10.1016/S0016-5085(99)70013-2

10.1097/00054725-200211000-00003

10.1097/00054725-199911000-00004

10.1136/gut.2003.026252

Mitra P, Keese CR, Giaever I.Electric measurements can be used to monitor the attachment and spreading of cells in tissue culture.Biotechniques11: 504–510, 1991.

10.1159/000079152

10.1111/j.1365-2249.1995.tb03130.x

10.1152/ajpgi.2000.279.5.G851

10.1038/sj.embor.7400731

Oshitani N, Watanabe K, Nakamura S, Fujiwara Y, Higuchi K, Arakawa T.Dislocation of tight junction proteins without F-actin disruption in inactive Crohn's disease.Int J Mol Med15: 407–410, 2005.

10.1053/j.gastro.2004.09.001

10.1038/labinvest.3700316

10.1136/gut.52.7.988

10.1152/ajpgi.00202.2007

10.3748/wjg.v12.i27.4352

10.1007/s00384-003-0554-4

10.1007/s10620-005-2663-0

10.1097/00054725-200303000-00002

10.1152/ajpcell.00131.2005

10.2353/ajpath.2006.060681

Ukena S, Singh A, Dringenberg U, Engelhardt R, Seidler U, Hansen W, Bleich A, Bruder D, Franzke A, Rogler G, Suerbaum S, Buer J, Gunzer F, Westendorf A.Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.PLoS Biol2: e1308, 2007.

10.1146/annurev.physiol.68.040104.131404

Wagner RD, Warner T, Roberts L, Farmer J, Balish E.Colonization of congenitally immunodeficient mice with probiotic bacteria.Infect Immun65: 3345–3351, 1997.

10.1242/jcs.02630

10.1038/nature06005

10.1053/j.gastro.2006.11.022

10.1136/gut.2006.094375

10.1111/j.1462-5822.2006.00836.x